Political unrest could accelerate acquisitions
The political uproar that has followed in the wake of a number of US-based companies’ overseas acquisition strategies and shrewd tax maneuvers could intensify additional consolidation in the industry, says an analyst – and Danish companies could become targets as well.
by Leonora Beck
The past weekend offered the biggest ever acquisition in the medical device industry, as US-based market leader Medtronic conquered Irish-based rival Covidien in a deal valued at USD 42.9 billion. A few weeks prior to that, US-based drug group Pfizer failed in its bid to usurp British rival AstraZeneca for an amount of USD 118 billion.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Leerink: US investors look to Europe
For abonnenter
”We keep an eye on them, same as always”
For abonnenter
Novo stays away from the sector’s M&A frenzy
For abonnenter
